Please Wait.....
Report
North America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)
Market Report I 2022-09-25 I 127 Pages I The Insight Partners
The North America human papillomavirus (HPV) vaccine market is expected to grow from US$ 2,247.18 million in 2022 to US$ 2,964.96 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2022 to 2028.
The increase in programs for HPV awareness is one of the effective strategies to increase vaccination uptake and eliminate HPV-associated cancers. Dana-Farber Cancer Institute, Boston, US, has initiated the HPV and Related Cancers Outreach Program, which aims to reduce the HPV-related cancer burden in the community through education and vaccination. The outreach program has been developed to address common barriers to vaccination. Through workshops with the City of Boston and the Boston Public Health Commission, youth-serving organizations, Boston Public Schools, Area Health Education Centers organizations, and faith-based and other community-based organizations, people in Boston have been educated about it. Therefore, the growing number of awareness programs is likely to fuel the market growth in the next few years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America human papillomavirus (HPV) vaccine market . The North America human papillomavirus (HPV) vaccine market is expected to grow at a good CAGR during the forecast period.
North America Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
North America Human Papillomavirus (HPV) Vaccine Market Segmentation
The North America human papillomavirus (HPV) vaccine market is segmented based on type, dosage, age, application, end user, and country. Based on type, the North America human papillomavirus (HPV) vaccine market is segmented into 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. The quadrivalent HPV vaccine segment would dominate the market in 2022. In terms of dosage, the North America human papillomavirus (HPV) vaccine market is bifurcated into 2 dose and 3 dose. The 2 dose segment would dominate the market in 2022. Based on age, the North America human papillomavirus (HPV) vaccine market is bifurcated into 9 to 14 years and 15 to 45 years. The 9 to 14 years segment would dominate the market in 2022. In terms of application, the North America human papillomavirus (HPV) vaccine market is bifurcated into HPV-attributable cancer and genital warts. The HPV-attributable cancer segment would dominate the market in 2022. Based on end user, the North America human papillomavirus (HPV) vaccine market is segmented into doctors office, community health clinics, school-based health centers, health departments, hospitals, and others. The hospitals segment would dominate the market in 2022. Based on country, the North America human papillomavirus (HPV) vaccine market has been categorized into the US, Canada, and Mexico. The US would dominate the market in 2022.
ChengDu Institute of Biological Products Co., Ltd.; GlaxoSmithKline plc.; Inovio Pharmaceuticals; Merck & Co., Inc.; R-Pharm; Sanofi; Serum Institute of India Pvt. Ltd; Vaccitech; and Walvax Biotechnology Co., Ltd. are among the leading companies in the North America human papillomavirus (HPV) vaccine market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Papillomavirus (HPV) Vaccines Market - By Type
1.3.2 North America Human Papillomavirus (HPV) Vaccines Market - By Dosage
1.3.3 North America Human Papillomavirus (HPV) Vaccines Market - By Age
1.3.4 North America Human Papillomavirus (HPV) Vaccines Market - By Application
1.3.5 North America Human Papillomavirus (HPV) Vaccines Market - By Distribution Channel
1.3.6 North America Human Papillomavirus (HPV) Vaccines Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Papillomavirus (HPV) Vaccine Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Papillomavirus (HPV) Vaccine Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of HPV Associated Diseases
5.1.2 Initiatives Taken by Health Organizations
5.2 Market Restraints
5.2.1 High Cost of HPV Vaccines
5.3 Market Opportunities
5.3.1 Growing Number of HPV Awareness Programs
5.4 Future Trends
5.4.1 Advancements in HPV Diagnostics Tests
5.5 Impact Analysis
6. Human Papillomavirus (HPV) Vaccine Market- North America Analysis
6.1 North America Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis
7. North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Type
7.1 Overview
7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)
7.3 9-valent HPV vaccine
7.3.1 Overview
7.3.2 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.4 Quadrivalent HPV vaccine
7.4.1 Overview
7.4.2 Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.5 Bivalent HPV Vaccine
7.5.1 Overview
7.5.2 Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
8. North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Dosage
8.1 North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
8.2 2 Dose
8.2.1 Overview
8.2.2 2 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
8.3 3 Dose
8.3.1 Overview
8.3.2 3 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Age
9.1 North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
9.2 9 to 14 Years
9.2.1 Overview
9.2.2 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
9.3 to 45 Years
9.3.1 Overview
9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Application
10.1 North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
10.2 HPV-attributable Cancer
10.2.1 Overview
10.2.2 HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
10.3 Genital Warts
10.3.1 Overview
10.3.2 Genital Warts: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
11. North America Human Papillomavirus (HPV) Vaccine Market Analysis - By End User
11.1 Overview
11.2 North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
11.3 Doctor Office
11.3.1 Overview
11.3.2 Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
11.4 Community Health Clinics
11.4.1 Overview
11.4.2 Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
11.5 School-based Health Centers
11.5.1 Overview
11.5.2 School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
11.6 Health Departments
11.6.1 Overview
11.6.2 Health Departments Market Revenue and Forecast to 2028 (US$ Million)
11.7 Hospitals
11.7.1 Overview
11.7.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
11.8 Others
11.8.1 Overview
11.8.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. North America Human Papillomavirus (HPV) Vaccine Market - Country Analysis
12.1 North America: Human Papillomavirus (HPV) Vaccine Market
12.1.1 Overview
12.1.2 North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
12.1.2.1 US: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 US: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 US: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.2.1.4 US: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.2.1.5 US: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.2.1.6 US: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.2.1.7 US: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.1.2.2 Canada: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 Canada: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 Canada: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.2.2.4 Canada: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.2.2.5 Canada: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.2.2.6 Canada: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.2.2.7 Canada: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.1.2.3 Mexico: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 Mexico: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.2.3.4 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.2.3.5 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.2.3.6 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.2.3.7 Mexico: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Merck & Co., Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Serum Institute of India Pvt. Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Walvax Biotechnology Co., Ltd.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Inovio Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Vaccitech
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ChengDu Institute of Biological Products Co., Ltd.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Sanofi
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 R-Pharm
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Papillomavirus (HPV) Vaccine Market, Revenue and Forecast, 2019-2028 (US$ Mn)
Table 2. US Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 4. US Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 5. US Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Inorganic Growth Strategies
Table 18. Recent Organic Growth Strategies
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Papillomavirus (HPV) Vaccines Market Segmentation
Figure 2. North America Human Papillomavirus (HPV) Vaccines Market, By Country
Figure 3. North America Human Papillomavirus (HPV) Vaccine Market Overview
Figure 4. North America Human Papillomavirus (HPV) Vaccines Market, By Type
Figure 5. North America Human Papillomavirus (HPV) Vaccines Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Human Papillomavirus (HPV) Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. North America Human Papillomavirus (HPV) Vaccine Market- Revenue Forecast and Analysis
Figure 10. By Type: Market Analysis and Forecast 2022 and 2028 (%)
Figure 11. North America 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
Figure 15. North America 2 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America 3 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
Figure 18. North America 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America 15 to 45 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
Figure 21. North America HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Genital Warts: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
Figure 24. North America Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Health Departments Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Hospitals Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America: Human Papillomavirus (HPV) Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
Figure 32. US: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Canada: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Mexico: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security